Literature DB >> 32388624

Ocular surface involvement in patients with neurofibromatosis type 1 syndrome.

Antonietta Moramarco1, M Sacchetti2, F Franzone2, M Segatto3, D Cecchetti2, E Miraglia4, V Roberti4, C Iacovino4, S Giustini4.   

Abstract

PURPOSE: The aim of this study is to evaluate ocular surface morphological and functional changes in patients with neurofibromatosis type 1 (NF1).
METHODS: Twenty-eight patients with NF1 and 14 healthy subjects were included in this study. All participants underwent a medical history collection, a complete ophthalmological examination including slit lamp exam and assessment of best-corrected visual acuity (BCVA), corneal sensitivity, and lacrimal function (Schirmer test and fluorescein tear break-up time test). Corneal nerves' morphology and endothelial cells density were evaluated by in vivo corneal confocal microscopy (IVCM). Tear and conjunctiva epithelium samples were collected to evaluate nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) tear levels and conjunctival expression of their receptors TrkA and p75NTR.
RESULTS: Patients with NF1 showed a significant decrease of FTBUT when compared with healthy subjects (p < 0.001). Corneal sensitivity was ≤ 50 mm in 46% of NF1 patients. IVCM showed a significant increase of corneal nerve branching and of corneal endothelial cells density. No significant difference was observed between the two groups on NGF and BDNF tear levels and conjunctival expression of their receptors.
CONCLUSION: This study demonstrated the presence of ocular surface changes in NF-1 patients including decrease of tear stability and of corneal sensitivity. Patients with NF1 also showed changes of corneal endothelial cells' density.

Entities:  

Keywords:  Break up time; Corneal endothelial cells; Neurofibromatosis type 1; Neurotrophins; Ocular surface

Mesh:

Year:  2020        PMID: 32388624     DOI: 10.1007/s00417-020-04717-5

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  4 in total

1.  Neuroretinal dysfunction in patients affected by neurofibromatosis type 1.

Authors:  Antonietta Moramarco; Luca Lucchino; Fabiana Mallone; Michela Marcelli; Ludovico Alisi; Vincenzo Roberti; Sandra Giustini; Alessandro Lambiase; Marcella Nebbioso
Journal:  Int J Ophthalmol       Date:  2022-05-18       Impact factor: 1.645

2.  Neurofibromatosis Type 1: Ocular Electrophysiological and Perimetric Anomalies.

Authors:  Marcella Nebbioso; Antonietta Moramarco; Alessandro Lambiase; Sandra Giustini; Marco Marenco; Emanuele Miraglia; Pasquale Fino; Chiara Iacovino; Ludovico Alisi
Journal:  Eye Brain       Date:  2020-10-21

3.  An update on choroidal abnormalities and retinal microvascular changes in neurofibromatosis type 1.

Authors:  Fabiana Mallone; Luca Lucchino; Sandra Giustini; Alessandro Lambiase; Antonietta Moramarco
Journal:  Orphanet J Rare Dis       Date:  2022-06-13       Impact factor: 4.303

4.  Autophagy-lysosome pathway alteration in ocular surface manifestations in Fabry disease patients.

Authors:  Marco Marenco; Marco Segatto; Marta Sacchetti; Pietro Mangiantini; Francesca Giovannetti; Rocco Plateroti
Journal:  Orphanet J Rare Dis       Date:  2022-07-23       Impact factor: 4.303

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.